JP2022524152A5 - - Google Patents

Info

Publication number
JP2022524152A5
JP2022524152A5 JP2021553788A JP2021553788A JP2022524152A5 JP 2022524152 A5 JP2022524152 A5 JP 2022524152A5 JP 2021553788 A JP2021553788 A JP 2021553788A JP 2021553788 A JP2021553788 A JP 2021553788A JP 2022524152 A5 JP2022524152 A5 JP 2022524152A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
group
hydroxybutyrate
lbw
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021553788A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022524152A (ja
JP7287709B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/019174 external-priority patent/WO2020185368A1/en
Publication of JP2022524152A publication Critical patent/JP2022524152A/ja
Publication of JP2022524152A5 publication Critical patent/JP2022524152A5/ja
Application granted granted Critical
Publication of JP7287709B2 publication Critical patent/JP7287709B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021553788A 2019-03-14 2020-02-21 ケトン体化合物用風味マスキング製剤 Active JP7287709B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962818208P 2019-03-14 2019-03-14
US62/818,208 2019-03-14
PCT/US2020/019174 WO2020185368A1 (en) 2019-03-14 2020-02-21 Taste-masking formulation for ketone body compounds

Publications (3)

Publication Number Publication Date
JP2022524152A JP2022524152A (ja) 2022-04-27
JP2022524152A5 true JP2022524152A5 (https=) 2023-03-07
JP7287709B2 JP7287709B2 (ja) 2023-06-06

Family

ID=72426308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021553788A Active JP7287709B2 (ja) 2019-03-14 2020-02-21 ケトン体化合物用風味マスキング製剤

Country Status (11)

Country Link
US (1) US12225919B2 (https=)
EP (1) EP3937656B1 (https=)
JP (1) JP7287709B2 (https=)
KR (1) KR102865708B1 (https=)
CN (1) CN113543652B (https=)
BR (1) BR112021017954A2 (https=)
CA (1) CA3097783C (https=)
IL (1) IL278422B (https=)
MX (1) MX2021010945A (https=)
MY (1) MY204412A (https=)
WO (1) WO2020185368A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026003892A1 (en) 2024-06-28 2026-01-02 Dr. Schär S.P.A. Ketogenic food formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003342223A (ja) * 2002-05-30 2003-12-03 Kanebo Ltd 包接化合物およびこれを含有する組成物
EP1901622B1 (en) * 2005-05-23 2014-07-16 Intercontinental Great Brands LLC Taste potentiator compositions and beverages containing same
US7807718B2 (en) 2006-06-30 2010-10-05 Sami A. Hashim Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
EP2195656A4 (en) 2007-08-21 2011-10-19 Senomyx Inc HUMAN T2R BITTERITY RECEPTORS AND USES THEREOF
EP2268282B1 (en) * 2008-04-25 2014-10-29 Apotex Technologies Inc. Liquid formulation for deferiprone with palatable taste
GB201002983D0 (en) * 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
BR112013031406B1 (pt) * 2011-06-08 2022-02-22 Lts Lohmann Therapie-Systeme Ag Tira de filme oral comestível e seu método de preparação
GB201206192D0 (en) * 2012-04-05 2012-05-23 Tdeltas Ltd Ketone bodies and ketone body esters and for maintaining or improving muscle power output
US9827320B2 (en) * 2014-02-27 2017-11-28 The Procter & Gamble Company Compositions with reduced bitter taste perception
US10292952B2 (en) * 2016-03-11 2019-05-21 Axcess Global Sciences, Llc Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis
US20160376263A1 (en) * 2016-07-26 2016-12-29 Senomyx, Inc. Bitter taste modifiers including substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones and compositions thereof
US20180177753A1 (en) 2016-12-23 2018-06-28 Neuroenergy Ventures, Inc. Glyceryl 3-hydroxybutyrates for migraine symptom management
US20200222353A1 (en) 2019-01-14 2020-07-16 Christopher David Thompson Ketone ester and ketone salt compositions and methods for using the same

Similar Documents

Publication Publication Date Title
CA1274543A (fr) (-)-benzhydryl-sulfinylacetamide, procede de preparation et utilisation en therapeutique
JPH07285860A (ja) L−dopaエステルの組成物
JPH0460973B2 (https=)
CN110317192A (zh) 一类具有降解雄激素受体活性的化合物
EP2595620A2 (fr) Traitement d'une pathologie liee a un effet excessif du tnf par un compose de benzene sulfonamide
JP2017200931A (ja) スルフォラファンの単離及び精製
KR102303892B1 (ko) 신규한 브롬화 퓨라논 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
JP2022524152A5 (https=)
CA3097783C (en) Taste-masking formulation for ketone body compounds
JP2015042625A (ja) 口腔用組成物
HU181693B (en) Process for producing compositions containing oxytetracyclin
EP1358159B1 (fr) Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations
CN115397470A (zh) 具有改善的自愿接受度的组合物
RU2593203C2 (ru) Пантенола докозагексаеноат и его применение для лечения и предупреждения сердечно-сосудистых заболеваний
JP7043784B2 (ja) 発毛剤
US6201011B1 (en) Therapeutic agent for allergic dermatitis
FR2527078A1 (fr) Compositions pharmaceutiques anti-ulceres
HUP0203321A2 (hu) (6-Metoxi-2-naftil)-ecetsav prodrug készítmények gyulladás kezelésére
GEAP202516774A (en) Compactable oral formulations of ibutamoren
CH654011A5 (fr) Phosphoramides, procede pour leur preparation et compositions pharmaceutiques les contenant.
LU85331A1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
WO2021021552A1 (en) Synthesis of pro-resolving analogs and compositions therefor
CZ2019743A3 (cs) Fenolické dihydrobenzofuranové deriváty, léčebné a kosmetické přípravky obsahující tyto deriváty a jejich použití
CH632763A5 (en) Triazolothiadiazine derivatives and processes for preparing them
JP5782299B2 (ja) 神経因性疼痛用鎮痛剤